| PHA |
Pharming september 2018
i sold my position yesterday (lucky). My thoughts on the course, in September 2017 the stock went from 0.44 - 0.85, based on two things the sBLA filing with the FDA and the expansion of the acute mark...
|
Oztrader |
| PHA |
Pharming september 2018
Interesting development from BioCryst. www.fiercebiotech.com/biotech/biocrys...
|
Oztrader |
| PHA |
Pharming januari 2018
Ive read through the 221 pages and my first comment, we talk about the share price going up and green, but what some of these patients have gone through is really brutal. Hearing their stories ma...
|
Oztrader |
| PHA |
Pharming januari 2018
Not sure if this was posted: www.tradingview.com/chart/PHARM/DGq73...
|
Oztrader |
| PHA |
Pharming het aandeel van 2017 deel 2
What is required now is calm. Before the Q2 result the shares peaked at 0.49, then dropped down to 0.41 (-20%). Profit takers made their money. I also took my money at 0.45 (and missed the jump when t...
|
Oztrader |
| PHA |
Pharming het aandeel van 2017
So pharming is doing that well they no longer need to post the analyst reports or their Q3 presentation. lol. ...
|
Oztrader |
| PHA |
Pharming het aandeel van 2017
Yeah i was wrong about my Q3 expectations - I thought the IMF data in the Stifel report was accurate about the 5.3mil run rate per month for Q3. ...
|
Oztrader |
| PHA |
Pharming het aandeel van 2017
Pharming has delivered an operating profit and generated positive net cash flow during each of the last three full quarters since we regained the US rights for RUCONEST and the Company is [b]clo...
|
Oztrader |
| PHA |
Pharming het aandeel van 2017
We have therefore been supplying considerable amounts of RUCONEST free-of-charge to cover treatment of attacks for the period during which those patients are being cleared for RUCONEST...
|
Oztrader |
| PHA |
Pharming het aandeel van 2017
The stock price should stabilise now. Maybe a small pick up once the American exchanges open and should creep up to 0.90 in the coming months. The big next rise will come on news of prophylactic use i...
|
Oztrader |
| PHA |
Pharming het aandeel van 2017
The news of this morning was really really great. Net profit was impacted by the rising share price in the quarter, I do hope the run rate does slow slightly and pharming invests in other pipelines, b...
|
Oztrader |
| PHA |
Pharming het aandeel van 2017
23.96m - Fake news. Just look at the stock price. ...
|
Oztrader |
| PHA |
Pharming het aandeel van 2017
The only thing in the back of my mind which makes me a little optimistic about tomorrows results is that pharming has not come out with any significant news in the last week (except for the warrants)....
|
Oztrader |
| PHA |
Pharming het aandeel van 2017
I think tomorrow the Q3 figures will be below 15mil euros due to currency headwinds. What I am more interested in is the level of operating profit and net profit. Will we see the same as Q1 on operati...
|
Oztrader |
| PHA |
Pharming het aandeel van 2017
Has anybody sent Michael Vlemmix from KBC Securities a note to inform him he missed the boat? ...
|
Oztrader |
| PHA |
Pharming het aandeel van 2017
I use google translate because I do enjoy reading your comments and insights. ...
|
Oztrader |
| PHA |
Pharming het aandeel van 2017
I think all the recent news releases out of pharming (before Q3 result) as well as analyst upgrades is to buffer what could be perceived as disappointing Q3 figures. The quarter on quarter growth in U...
|
Oztrader |
| PHA |
Pharming het aandeel van 2017
Im back onboard, bought at 0.31 sold at 0.45. Missed the boat on the recent hike and have bought now at the top. I think the Q3 result will be a little disappointing because of the EUR/USD - Q2 a...
|
Oztrader |
| PHA |
Pharming het aandeel van 2017
Not sure if this is a re-post but the stifel update. www.pharming.com/wp-content/uploads/2...
|
Oztrader |
| PHA |
Pharming het aandeel van 2017
www.more-ir.de/d/15213.pdfMy Dutch is not so good but the above link could be interesting. ...
|
Oztrader |